Journals / Eastern Journal of Medicine / 2016 / Cilt: 21 - Sayı: 4

Cardiac hypertrophy and heart failure: From the case to review of literature

Pages
191–196
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The analysis of the pathogenetic mechanisms, which may determinate the fatal event in case of cardiac hypertrophy, shows that in the described case the death cause can be the onset of heart failure in presence of cardiomegaly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In response to an increased workload due to physiological or pathological stimuli, the heart may undergo a process of growth with increased muscle mass called cardiac hypertrophy.
📊
Key Findings & Data:The latter represents an important cause of death and so the cardiac hypertrophy increases the cardiovascular morbidity and mortality.
💡
Conclusion & Impact:The analysis of the pathogenetic mechanisms, which may determinate the fatal event in case of cardiac hypertrophy, shows that in the described case the death cause can be the onset of heart failure in presence of cardiomegaly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In response to an increased workload due to physiological or pathological stimuli, the heart may undergo a process of growth with increased muscle mass called cardiac hypertrophy. It is a particular mechanism of long term compensation used by the heart to adapt permanently to a greater workload. Although, through its peculiar structural, molecular and metabolic characteristics, in early stage the hypertrophy allows to maintain an adequate cardiac function, after a variable period of time, the same characteristics promote the evolution to contractile dysfunction and heart failure. The latter represents an important cause of death and so the cardiac hypertrophy increases the cardiovascular morbidity and mortality. In this paper we report a rare case of extremely high degree of concentric cardiac hypertrophy, with a heart weight of 1050 g and longitudinal diameter of 16.5 cm, transverse diameter of 16 cm and antero-posterior diameter of 9 cm. The thickness of the left ventricle free wall was 4.2 cm, of the septum 4.3 cm and at the apex level 3.5 cm. These data, compared with those described in scientific literature, indicate the exceptional nature of our necropsy finding of a huge cardiac hypertrophy. The analysis of the pathogenetic mechanisms, which may determinate the fatal event in case of cardiac hypertrophy, shows that in the described case the death cause can be the onset of heart failure in presence of cardiomegaly.

🔖

Cite This Article

MASSONİ1, F., RİCCİ, L., SİMEONE, C., RİCCİ, S. (2016). Cardiac hypertrophy and heart failure: From the case to review of literature. Eastern Journal of Medicine, Cilt: 21 - Sayı: 4, 191–196. https://ajindex.com/articles/222605

References (18)

  1. Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation 2000; 102: 649-654
  2. Gosse P, Dallocchio M. Left ventricular hypertrophy: epidemiological prognosis and associated critical factors. Eur Heart J 1993; 14: 16-21
  3. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 2007; 34: 255-262
  4. Bella JN, Göring HHH. Genetic epidemiology of left ventricular hypertrophy. Am J Cardiovasc Dis 2012; 2: 267-278
  5. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341
  6. Katz AM. Maladaptive growth in the failing heart: the cardiomyopathy of overload. Cardiovasc Drugs Ther 2002; 16: 245-249
  7. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005; 365: 1877-1889
  8. Morimoto S, Sekiguchi M, Hiramitsu S, et al. Contribution of cardiac muscle cell disorganization to the clinical features of hypertrophic cardiomyopathy. Heart Vessels 2000; 15: 149-158
  9. Cummings PM, Le BH, Lopes MBS. Postmortem findings in morbidly obese individuals dying after gastric bypass procedures. Hum Pathol 2007; 38: 593-597
  10. Di Paolo M, Guidi B, Bugelli V, Naccarato GA. Sudden death of a sportsman. An unusual case of idiopathic form of pulmonary hypertension. Int J Legal Med 2012; 126: 52
  11. Giraldo RD, Guarin CV, Viloria VB. Sudden death: intramural coronary artery. Int J Legal Med 2012; 126: 196
  12. Schoen FJ, Mitchell RN. The Heart. In: Kumar V, Abbas AK, Fausto N, Aster J. Robbins and Cotran Pathologic Basis of Disease - 8th ed. Philadelphia: Saunders Elsevier; 2010, p. 529-587
  13. Hort W. Myocardial hypertrophy. Light microscopic findings on the myocardium. Blood supply. Ventricular dilatation and heart failure. Basic Res Cardiol 1977; 72: 203-208
  14. Dorn GW. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 2007; 49: 962- 970
  15. Norton JM. Toward consistent definitions for preload and afterload. Adv Physiol Educ 2001; 25: 53-61
  16. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010; 128: 191-227
  17. Van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 2013; 123: 37-45
  18. Brower GL, Gardner JD, For